Table 1. Mean ± standard deviation (SD) of body mass index (BMI) and biochemical characteristics of type 2 diabetic patients and normal control groups.
| Multiple Comparisons (Post Hoc analysis) | Diabetic and control groups | ||||||
| Parameters | Metformin (N= 64 ) | Glibenclamide (N= 40 ) | Insulin (N= 58) | Control (N= 47 ) | P value | ||
| Fasting Blood Sugar (mg/dl) | 161.9 ± 58 | 214.7 ± 91.3 | 193.6 ± 80 | 92.7 ± 12 | 0.00 | ||
| Metformin | - | 0.001 | 0.007 | 0.00 | |||
| Glibenclamide | 0.001 | - | 0.17 | 0.00 | |||
| Insulin | 0.007 | 0.17 | - | 0.00 | |||
| Control | 0.00 | 0.00 | 0.00 | - | |||
| Glycated Hemoglobin (HbA1c ) (%) | 7.7 ± 1.8 | 9.5 ± 2.4 | 8.4 ± 2.2 | 5 ± 0.4 | 0.00 | ||
| Metformin | - | 0.036 | 0.00 | ||||
| Glibenclamide | 0.00 | - | 0.017 | 0.00 | |||
| Insulin | 0.036 | 0.017 | - | 0.00 | |||
| Control | 0.00 | 0.00 | 0.00 | - | |||
| Body Mass Index (kg/ m2) | 29 ± 6.1 | 29.4 ± 4.7 | 26 ± 5.6 | 24.4 ± 0.5 | 0.002 | ||
| Metformin | - | 0.72 | 0.004 | 0.004 | |||
| Glibenclamide | 0.72 | - | 0.012 | 0.009 | |||
| Insulin | 0.004 | 0.012 | - | 0.82 | |||
| Control | 0.004 | 0.009 | 0.82 | - | |||
| Serum Uric Acid (mg/dl) | 5.8 ± 2.7 | 6.4 ± 2 | 4.9 ± 1.8 | 4.7 ± 0.9 | 0.001 | ||
| Metformin | - | 0.19 | 0.02 | 0.007 | |||
| Glibenclamide | 0.19 | - | 0.003 | 0.001 | |||
| Insulin | 0.02 | 0.003 | - | 0.6 | |||
| Control | 0.007 | 0.001 | 0.6 | - | |||